Article
NCODA, FCS Announce New Oncology Stakeholder Education Exchange Program
NCODA and Florida Cancer Specialists & Research Institute jointly announced the development of a novel oncology stakeholder education exchange program.
Cazenovia, NY, August 16, 2022 – Florida Cancer Specialists & Research Institute (FCS) jointly announced with NCODA the development of a virtual learning platform that offers focused education for governance-level Board members, disease-state experts, and generalists.
FCS will be the first to utilize this new program, with the latest updates and detailed information to be made available in real-time at the user’s convenience on NCODA’s platform, Rxchange.
Lucio Gordan, MD, FCS chief medical officer for Therapeutics and Analytics, said, “organizing the education and information exchange between providers and other health care stakeholders has been long overdue. Rxchange will greatly enhance the 2-way flow of information in an environment of rapid and unprecedented developments in cancer care and help to enhance overall patient care.“
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
